About me
Jason Riggs is the Head of Research and Development at Microsize and a Principal
Scientist at The Solubility Company. He has over 15 years of Pharmaceutical Sciences
experience in biopharmaceutical assessment, solid-state characterization, form
selection, formulation development, and chemical stability evaluation. His team at
Microsize develops micronization and classification processes on API and excipients
from Discovery to Commercial scales. In addition, his team onboards complimentary
technologies such as SoluMatrix™ nanoparticles, AustinPx’s KinetiSol™ amorphous
solid dispersion platform, and The Solubility Company’s SPA® methodology to measure
solubility and dissolution rates. Jason has lead Discovery Pharmaceutics and
Pharmaceutical Sciences CMC teams at Johnson and Johnson where he helped
transition over 20 compounds into the clinic. He obtained his Ph.D. and M.S. in
Physical Organic Chemistry from Cornell University and his B.S. from Drexel University
in Chemistry.
